pyrroles has been researched along with r18 peptide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Dong, S; Kang, S; Khoury, HJ; Lonial, S; Viallet, J | 1 |
1 other study(ies) available for pyrroles and r18 peptide
Article | Year |
---|---|
Targeting 14-3-3 sensitizes native and mutant BCR-ABL to inhibition with U0126, rapamycin and Bcl-2 inhibitor GX15-070.
Topics: 14-3-3 Proteins; Amino Acid Sequence; Antineoplastic Agents; Apoptosis; Benzamides; Butadienes; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Forkhead Box Protein O3; Forkhead Transcription Factors; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Indoles; Intracellular Signaling Peptides and Proteins; K562 Cells; Molecular Sequence Data; Mutation, Missense; Neoplasm Proteins; Nitriles; Peptides; Piperazines; Point Mutation; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Recombinant Fusion Proteins; Signal Transduction; Sirolimus | 2008 |